×
Atai Life Sciences EBITDA 2020-2025 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atai Life Sciences ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Atai Life Sciences EBITDA 2020-2025 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atai Life Sciences ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Quest Diagnostics (DGX)
$18.3B
DaVita (DVA)
$11.2B
Encompass Health (EHC)
$10.4B
Chemed (CHE)
$8.5B
Option Care Health (OPCH)
$5.3B
Elanco Animal Health (ELAN)
$4.2B
RadNet (RDNT)
$3.7B
Amedisys (AMED)
$3B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$1.8B
Astrana Health (ASTH)
$1.6B
U.S Physical Therapy (USPH)
$1B
Pennant (PNTG)
$907M
Aveanna Healthcare Holdings (AVAH)
$886M
Daxor (DXR)
$36M
Ontrak (OTRK)
$6M
MEDIROM Healthcare Technologies (MRM)
$4M
Psychemedics (PMD)
$0M